X4 Pharmaceuticals (XFOR) Price to Book (2019 - 2026)

X4 Pharmaceuticals (XFOR) has reported Price to Book for 8 consecutive years, with 3.8 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book changed 0.34% year-over-year to 3.8; the trailing twelve-month figure through Jun 2026 stood at 3.8 (changed 0.34% YoY), and the FY2025 full-year result was 0.91, down 83.96% from the prior year.
• Price to Book rose to 3.8 in Q2 2026 per XFOR's latest filing, from 3.1 in the prior quarter.
• Across five years, Price to Book topped out at 8049.85 in Q1 2024 and bottomed at 0.91 in Q4 2025.
• Historically, Price to Book has averaged 479.21 across 5 years, with a median of 27.69 in 2022.
• The sharpest annual moves came in 2024 and 2025: Price to Book jumped 12941.83% in 2024, then sank 99.98% in 2025.
• Over 5 years, Price to Book stood at 25.56 in 2022, then soared by 242.52% to 87.53 in 2023, then sank by 93.53% to 5.66 in 2024, then slumped by 83.96% to 0.91 in 2025, then jumped by 317.96% to 3.8 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 3.8, 3.1, and 0.91 for Q2 2026, Q1 2026, and Q4 2025 respectively.